Sintx Technologies, Inc. (SINT) stock
Close on Nov 11, 2026Market cap $10.80MP/E –Yield –
Sintx Technologies, Inc. grew revenue 160.8% to $3.31M over the twelve months to Sep 30, 2026. Free cash flow was -$9.25M. At the latest close the market valued the company at $10.80M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $10.80M
- P/E ratio
- –
- Price to sales
- 3.26
- Price to book
- 3.18
- Dividend yield
- –
- Free cash flow yield
- -85.66%
Fundamentals
- Revenue
- $3.31M
- Net income
- -$9.34M
- EPS, diluted
- -$2.26
- Free cash flow
- -$9.25M
- Book value per share
- $0.51
- Diluted shares
- 7M
Trading
- Previous close
- $1.55
- Open
- $1.79
- Day's range
- $1.51 – $1.79
- Volume
- 39,171
- Average volume (20 days)
- 25,365
- Beta (5 years)
- 1.59
- 52-week range
- $1.40 – $4.46
- RSI (14 days)
- 42.1
- Volatility (1 year)
- 70.1%
- Relative volume
- 0.43×
- WACC
- 12.8%
Market cap history
Month-end market cap since 2015, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | SINT | S&P 500 | Difference | SINT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -23.2% | -2.4% | −20.8 pts | ||
| 3 months | -8.5% | -1.2% | −7.3 pts | ||
| Year to date | -58.0% | +12.3% | −70.3 pts | ||
| 1 year | -55.9% | +12.4% | −68.3 pts | ||
| 3 years | -98.0% | +78.8% | −176.8 pts | -72.9% | +21.4% |
| 5 years | -100.0% | +75.2% | −175.2 pts | -84.9% | +11.9% |
| 10 years | -100.0% | +311.1% | −411.1 pts | -77.7% | +15.2% |
Fourteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Sintx Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Update
- News
About Sintx Technologies
Surgical & Medical Instruments & Apparatus
SINTX Technologies develops, manufactures, and commercializes advanced silicon nitride ceramics, composites, and devices for medical, antipathogenic, and technical applications. The company provides biomedical solutions specializing in silicon nitride for musculoskeletal and antipathogenic uses, including spinal fusion implants and reconstructive foot and ankle osteotomy wedge systems. In addition, it fabricates ceramic components for electrical, aerospace, and industrial sectors, alongside antipathogenic powders intended for incorporation into masks, drapes, filters, sutures, and wound care devices. SINTX serves commercial customers in medical and industrial markets, as well as government agencies.
Company profile, executives and historySintx Technologies stock: common questions
What is Sintx Technologies's stock price?
SINT closed at $1.62 on Nov 11, 2026, up 4.52% on the day. Over the past 52 weeks it traded between $1.40 and $4.46.
What is Sintx Technologies's market cap?
Sintx Technologies was worth $10.80M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is SINT's P/E ratio?
Sintx Technologies lost money over the twelve months to Sep 30, 2026 (diluted EPS -$2.26), so it has no meaningful P/E ratio.
How much revenue does Sintx Technologies make?
Sintx Technologies reported revenue of $3.31M for the twelve months to Sep 30, 2026, up 160.8% from a year earlier.
Does Sintx Technologies pay a dividend?
No. Sintx Technologies has not paid a cash dividend over the last twelve months.
How has SINT stock performed over the past year?
Including dividends, SINT returned -55.9% over the past year, against +12.4% for the S&P 500.
How many SINT shares are sold short?
0M shares were sold short at the latest FINRA report, 2.01% of the float, or 7.3 days of average trading volume.
Who are Sintx Technologies's competitors?
Companies most similar to Sintx Technologies by business, industry and size include TNON, FEMY, VJET, AURX, INBS.
See a number that looks wrong?